Safety and Antiviral Effects of Nebulized PC786 in a Respiratory Syncytial Virus Challenge Study.
J Infect Dis
; 225(12): 2087-2096, 2022 06 15.
Article
in En
| MEDLINE
| ID: mdl-33216113
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Respiratory Syncytial Virus Infections
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
J Infect Dis
Year:
2022
Document type:
Article
Affiliation country:
Estados Unidos